echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Organic Chemistry Topics > Organic Chemistry Project > The 13th Five-Year Plan for Biotechnology Innovation: Over 4% of GDP

    The 13th Five-Year Plan for Biotechnology Innovation: Over 4% of GDP

    • Last Update: 2022-02-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    It was learned from the website of the Ministry of Science and Technology on May 10 that, in order to accelerate the development of biotechnology and biotechnology industry, the Ministry of Science and Technology formulated and issued the "Thirteenth Five-Year Plan for Biotechnology Innovation"
    .
    By 2020, achieve the overall "parallel running" and partial "leading" in this field
    .
    Basic research has achieved major original results, breakthroughs in a number of core key technologies, perfecting the biotechnology standard system, cultivating a number of companies with major innovation capabilities, and basically forming a relatively complete biotechnology innovation system.
    The biotechnology industry has begun to take shape and international competition Power is greatly improved
    .
    ? The plan proposes that during the "Thirteenth Five-Year Plan" period, three specific index systems will be formed: "improving the originality of biotechnology", "building a biotechnology innovation platform", and "strengthening biotechnology industrialization"
    .
    ? Improve the level of originality in biotechnology
    .
    Focus on the development of 20-30 leading new technologies, develop 30-50 major strategic new products, break through 50-80 major application key technologies, promote the establishment of basic general national standards in the field of biotechnology, and greatly improve the level of biotechnology
    .
    ? Create a biotechnology innovation platform
    .
    With the goal of accelerating the industrialization of biotechnology, promote the construction of several biotechnology innovation centers focusing on green biomanufacturing, innovative drug research and development, and biomedical engineering; build a national bioinformation center, human genetic resource bank, biological and medical big data, etc.
    Strategic resource platform, build a batch of resource sharing libraries and a shared service system
    .
    ? Strengthen the industrialization of biotechnology
    .
    To systematically establish a national biotechnology achievement catalog, improve the biotechnology transfer service system, build a number of biotechnology transfer and transformation centers; accelerate the construction of biotechnology specialized high-tech parks, and build 10-20 biomedical specialized parks and 5-10 biomedical parks with an output value of over 10 billion A bio-manufacturing professional park with an output value of more than 10 billion; the biotechnology industry accounts for more than 4% of GDP, which further enhances the competitiveness of the biotechnology industry
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.